John Newman
Stock Analyst at Canaccord Genuity
(3.93)
# 1,809
Out of 4,556 analysts
896
Total ratings
43.8%
Success rate
4.9%
Average return
Main Sectors:
Stocks Rated by John Newman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| REGN Regeneron Pharmaceuticals | Maintained: Buy | $875 | $675.19 | +29.59% | 118 | Jul 22, 2026 | |
| TYRA Tyra Biosciences | Maintained: Buy | $50 | $31.85 | +56.99% | 10 | Jul 21, 2026 | |
| RLAY Relay Therapeutics | Initiated Coverage: Buy | $29 | $19.30 | +50.26% | 1 | Jul 16, 2026 | |
| ACET Adicet Bio | Maintained: Buy | $18 | $8.12 | +121.67% | 27 | Jul 13, 2026 | |
| DCTH Delcath Systems | Maintained: Buy | $21 | $12.81 | +63.93% | 28 | Jul 10, 2026 | |
| MCRB Seres Therapeutics | Maintained: Buy | $22 | $5.25 | +319.05% | 68 | Jul 9, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Maintained: Buy | $23 | $8.72 | +163.76% | 3 | Jul 8, 2026 | |
| CMPX Compass Therapeutics | Maintained: Buy | $7 | $2.10 | +233.33% | 13 | Jul 1, 2026 | |
| MRKR Marker Therapeutics | Maintained: Buy | $8 | $1.27 | +529.92% | 13 | Jun 29, 2026 | |
| TNGX Tango Therapeutics | Maintained: Buy | $42 → $46 | $29.02 | +58.51% | 7 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $158 | $92.33 | +71.13% | 23 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $10.22 | +144.62% | 12 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $1.85 | +656.76% | 37 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $1.14 | +689.47% | 2 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $8.63 | +50.64% | 90 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $20.45 | +85.82% | 11 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.8585 | n/a | 19 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $3.06 | n/a | 18 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $300 | $8.62 | n/a | 34 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 | $8.13 | n/a | 45 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52 → $44 | $37.36 | n/a | 57 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $3 | $0.0042 | n/a | 24 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $352.81 | $17.83 | n/a | 2 | May 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $21.14 | n/a | 1 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $11.18 | n/a | 25 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.8948 | n/a | 12 | Mar 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14.10 | $9.82 | n/a | 1 | Mar 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $1.75 | n/a | 18 | Jun 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $6 | $1.58 | n/a | 18 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $5 | $66.74 | n/a | 17 | Jun 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $15.64 | n/a | 10 | Mar 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $16.64 | n/a | 11 | Mar 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $15.15 | n/a | 12 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $60 | $1.25 | n/a | 13 | Nov 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $15 | $2.19 | n/a | 4 | Oct 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $12.45 | n/a | 17 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $5.84 | n/a | 9 | Jul 26, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $90 | $31.23 | n/a | 1 | Jun 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $3.40 | n/a | 1 | May 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $31.80 | n/a | 1 | May 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $970.82 | n/a | 1 | Mar 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 → $6 | $1.31 | n/a | 5 | Mar 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $201 | $254.22 | n/a | 5 | Mar 3, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $6.29 | n/a | 1 | Jan 7, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $9 | $5.99 | n/a | 3 | Oct 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $127 | $203.16 | n/a | 45 | Dec 20, 2011 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $5 | $4.05 | n/a | 2 | Mar 15, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $80.59 | n/a | 1 | Jun 10, 2009 |
Regeneron Pharmaceuticals
Jul 22, 2026
Maintained: Buy
Price Target: $875
Current: $675.19
Upside: +29.59%
Tyra Biosciences
Jul 21, 2026
Maintained: Buy
Price Target: $50
Current: $31.85
Upside: +56.99%
Relay Therapeutics
Jul 16, 2026
Initiated Coverage: Buy
Price Target: $29
Current: $19.30
Upside: +50.26%
Adicet Bio
Jul 13, 2026
Maintained: Buy
Price Target: $18
Current: $8.12
Upside: +121.67%
Delcath Systems
Jul 10, 2026
Maintained: Buy
Price Target: $21
Current: $12.81
Upside: +63.93%
Seres Therapeutics
Jul 9, 2026
Maintained: Buy
Price Target: $22
Current: $5.25
Upside: +319.05%
BridgeBio Oncology Therapeutics
Jul 8, 2026
Maintained: Buy
Price Target: $23
Current: $8.72
Upside: +163.76%
Compass Therapeutics
Jul 1, 2026
Maintained: Buy
Price Target: $7
Current: $2.10
Upside: +233.33%
Marker Therapeutics
Jun 29, 2026
Maintained: Buy
Price Target: $8
Current: $1.27
Upside: +529.92%
Tango Therapeutics
Jun 29, 2026
Maintained: Buy
Price Target: $42 → $46
Current: $29.02
Upside: +58.51%
Jun 1, 2026
Maintained: Buy
Price Target: $158
Current: $92.33
Upside: +71.13%
May 18, 2026
Maintained: Buy
Price Target: $25
Current: $10.22
Upside: +144.62%
May 14, 2026
Maintained: Buy
Price Target: $14
Current: $1.85
Upside: +656.76%
May 13, 2026
Maintained: Buy
Price Target: $9
Current: $1.14
Upside: +689.47%
May 13, 2026
Maintained: Buy
Price Target: $13
Current: $8.63
Upside: +50.64%
May 6, 2026
Maintained: Buy
Price Target: $38
Current: $20.45
Upside: +85.82%
Nov 12, 2024
Maintained: Buy
Price Target: $5
Current: $0.8585
Upside: n/a
Nov 12, 2024
Maintained: Buy
Price Target: $10
Current: $3.06
Upside: n/a
Oct 1, 2024
Maintained: Buy
Price Target: $6 → $300
Current: $8.62
Upside: n/a
Aug 8, 2024
Maintained: Buy
Price Target: $43
Current: $8.13
Upside: n/a
Feb 16, 2022
Maintained: Buy
Price Target: $52 → $44
Current: $37.36
Upside: n/a
Aug 17, 2021
Maintained: Buy
Price Target: $7 → $3
Current: $0.0042
Upside: n/a
May 26, 2021
Maintained: Buy
Price Target: $352.81
Current: $17.83
Upside: n/a
May 12, 2021
Maintained: Buy
Price Target: $31
Current: $21.14
Upside: n/a
May 3, 2021
Maintained: Buy
Price Target: $45
Current: $11.18
Upside: n/a
Mar 25, 2021
Maintained: Buy
Price Target: $5
Current: $0.8948
Upside: n/a
Mar 9, 2020
Maintained: Buy
Price Target: $14.10
Current: $9.82
Upside: n/a
Jun 26, 2019
Reiterated: Buy
Price Target: $20
Current: $1.75
Upside: n/a
Aug 13, 2018
Maintained: Buy
Price Target: $31 → $6
Current: $1.58
Upside: n/a
Jun 27, 2017
Reiterated: Buy
Price Target: $8 → $5
Current: $66.74
Upside: n/a
Mar 10, 2017
Reiterated: Buy
Price Target: $10
Current: $15.64
Upside: n/a
Mar 1, 2017
Reiterated: Buy
Price Target: $12
Current: $16.64
Upside: n/a
Dec 30, 2016
Reiterated: Buy
Price Target: $10
Current: $15.15
Upside: n/a
Nov 9, 2016
Reiterated: Buy
Price Target: $6 → $60
Current: $1.25
Upside: n/a
Oct 11, 2016
Reiterated: Buy
Price Target: $6 → $15
Current: $2.19
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $34
Current: $12.45
Upside: n/a
Jul 26, 2016
Reiterated: Buy
Price Target: $3
Current: $5.84
Upside: n/a
Jun 13, 2016
Reiterated: Hold
Price Target: $90
Current: $31.23
Upside: n/a
May 13, 2016
Reiterated: Buy
Price Target: $30
Current: $3.40
Upside: n/a
May 2, 2016
Reiterated: Buy
Price Target: $26
Current: $31.80
Upside: n/a
Mar 31, 2016
Maintained: Buy
Price Target: $18
Current: $970.82
Upside: n/a
Mar 9, 2015
Maintained: Hold
Price Target: $8 → $6
Current: $1.31
Upside: n/a
Mar 3, 2015
Reiterated: Buy
Price Target: $201
Current: $254.22
Upside: n/a
Jan 7, 2015
Initiated Coverage: Buy
Price Target: $24
Current: $6.29
Upside: n/a
Oct 7, 2014
Downgraded: Hold
Price Target: $40 → $9
Current: $5.99
Upside: n/a
Dec 20, 2011
Rated: Buy
Price Target: $127
Current: $203.16
Upside: n/a
Mar 15, 2010
Downgraded: Sell
Price Target: $5
Current: $4.05
Upside: n/a
Jun 10, 2009
Maintained: Sell
Price Target: n/a
Current: $80.59
Upside: n/a